BankPlus Trust Department’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Sell
10,294
-1,008
-9% -$118K 0.31% 78
2026
Q1
$1.36M Buy
11,302
+445
+4% +$51.4K 0.36% 66
2025
Q4
$1.14M Hold
10,857
0.3% 73
2025
Q3
$911K Buy
10,857
+4,826
+80% +$397K 0.24% 84
2025
Q2
$477K Sell
6,031
-191
-3% -$15.2K 0.14% 111
2025
Q1
$558K Buy
6,222
+185
+3% +$17.3K 0.19% 95
2024
Q4
$601K Buy
+6,037
New +$622K 0.2% 94

Other funds holding MRK

BankPlus Trust Department's MRK Position: Q2 2026 in Review

BankPlus Trust Department reduced its Merck (MRK) stake by 8.9% in Q2 2026, selling an estimated $118K and leaving 10,294 shares worth $1.32M. The position accounts for 0.31% of the portfolio, ranked #78.

BankPlus Trust Department first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.36M in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • BankPlus Trust Department held 10,294 shares of Merck worth $1.32M as of Q2 2026.
  • BankPlus Trust Department sold 1,008 Merck shares in Q2 2026, an estimated $118K.
  • Merck made up 0.31% of BankPlus Trust Department's portfolio in Q2 2026, its #78 holding.
  • BankPlus Trust Department first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • BankPlus Trust Department's Merck position peaked at $1.36M in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.